Galapagos NV ADR
Price & Volume
Stats
See more52W Range | $22.36-$37.78 |
Market Cap | $2.1B |
Shares Short | 968,832 |
Financials
See moreRevenue (12 Mos) | $286.9M |
Revenue Growth (YoY) | 18.9% |
Gross Profit (12 Mos) | -$207.1M |
Diluted EPS | -$7.95 |
News
See moreYahoo Finance • 8 days ago
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Yahoo Finance • 8 days ago
Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes
Yahoo Finance • 19 days ago
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
Yahoo Finance • 19 days ago
Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025
About
CEO | Mr. Henry Gosebruch |
Address | Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 704 |
